AEG35156
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AEG35156, covering 2009-07-30 to 2011-07-13. Get the full timeline:
Most recent: Clinical Trial Update: AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen [Phase 2]